Delivery Order SPE2DX15D6041-SPE2DX24FBVBF
Award Date
4/22/24
Potential Completion Date
4/23/24
Potential Value
$3.7K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,566.08 for the supply of 4,565,520,865 units of the medication ondansetron hydrochloride 4 mg tablets. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is likely part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,662,094 units of the drug Ondansetron ODT 4 mg tablets. The firm-fixed-price contract has a ceiling value of $2,435.89 and a completion date of May 21, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,250 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $2,644.93 and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of July 26, 2024. Amerisourcebergen, through its Corporate Office...
This federal contract award, valued at $9,996.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,134,913 units of Ondansetron ODT 4 mg Tablets in 30-count packages. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,116,842 units of the drug Ondansetron ODT 4 mg tablets. The award has a ceiling value of $5,097.98 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,565,134,591 units of Ondansetron HCL 4 mg tablets in quantities of 500 per bottle. The contract has a ceiling value of $31,456.95 and an ultimate completion date of July 15, 2024. It was awarded on a Firm Fixed Price basis as a Delivery Order by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency component of the Department of Defense.
Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,939.89 firm fixed-price delivery order is for the supply of 4,565,215,136 units of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of July 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,994.86, is for the delivery of 4,566,523,540 units of Ondansetron HCL 4 MG tablets. It is a firm fixed-price delivery order contract with a completion date of November 25, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $11,144.26, is for the delivery of 4,564,416,404 units of the prescription drug Ondansetron ODT 4 mg tablets.
The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,231,328 units of Ondansetron ODT 4 mg Tablet 30s. The $4,095.04 firm-fixed-price Delivery Order has a completion date of July 24, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through...